InnoCan Pharma Corporation (CSE:INNO) is listed on the Canadian Securities Exchange in the Life Sciences sector, since September 24, 2019. The CSE has covered it in 2 stories and one CSE TV video since 2019.
CSE:INNOCompany profile on thecse.com
CSE’s Barrington Miller recently chatted with Iris Bincovich, the CEO of InnoCan Pharma Corporation (CSE:INNO) to discuss their recent patent application. In this chat, Iris shares how her team is designing CBD-loaded exosomes for targeting Coronavirus infected lung cells (2:15), how to improve CBD delivery through an injectable solution (7:53), and her prospects concerning a…
The CSE was happy to join InnoCan Pharma Corporation (CSE:INNO) for a Market Open from a special international location, with members of the InnoCan team ringing the bell on a beach in Tel Aviv, Israel. InnoCan Pharma Corporation is an Israel-based speciality pharmaceutical company that uses cannabis products to target health issues. The company specializes…
